(15 December 2023, Singapore) Building on the initial announcement made on 24 October 2023, Templewater is delighted to confirm the successful acquisition of OncoCare Medical (“OncoCare”) and Novena Heart Centre (“NHC”).
OncoCare, established in 2007, is a premier private medical oncology clinic group in Singapore, currently operating seven clinics strategically located at renowned hospitals and medical centers. Led by Dr. Miah Hiang Tay and Dr. Peter Ang, OncoCare boasts a network of 13 specialist oncologists, catering to both local and international patients.
NHC, also founded in 2007, is one of the largest multi-disciplinary cardiology groups in Singapore, operating three state-of-the-art cardiology clinics at prime locations in Singapore. With a strong roster of five cardiologists covering most subspecialties, NHC provides comprehensive inpatient and outpatient services.
Templewater's acquisition of OncoCare and NHC reflects its strategy of investing in high-potential markets and its commitment to the healthcare industry in Southeast Asia and the APAC region. Templewater is excited to work with both OncoCare and NHC to continue delivering quality healthcare services that have a profound impact on cancer and cardiovascular care in Singapore and beyond.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Templewater
Jason Li
Investor Relations
ir@templewater.com
+852 3187 5000
About Templewater Group
Founded in 2018, the Templewater Group (“Templewater”) is an alternative asset management firm headquartered in Hong Kong. Templewater provides investment solutions to institutions, entrepreneurs, and family offices across various asset classes including private equity, impact investing, and real estate.
Templewater’s private equity strategy focuses on mid-market control buyout opportunities in the Asia Pacific. With a team boasting global direct investments and buyout experience across sectors, Templewater actively partners with management teams to implement value creation tools and best practices, helping portfolio companies achieve their full potential. The firm currently manages capital on behalf of leading institutional investors.
In addition to private equity, Templewater has an impact investing strategy that focuses on growth capital for next-generation decarbonization technologies in the energy transition sector. By building mission-driven companies that deliver attractive financial returns while making positive social, environmental, and technological impact. Templewater contributes to the advancement of sustainable solutions.
To learn more about Templewater, please visit www.templewater.com
About OncoCare
Founded in 2007, OncoCare is one of the largest private medical oncology specialist centers in Singapore with seven clinics located at Singapore's premier hospitals and medical centers. It brings together medical oncologists with various sub-specialty and palliative specialist to provide a one-stop multi-disciplinary services, including diagnosis, cancer treatment, palliative treatment and other professional medical services for local and international patients in Singapore.
To learn more about OncoCare, please visit www.oncocare.sg
About NHC
Founded in 2007, NHC is one of the largest and fastest growing multi-disciplinary cardiology group practices in Singapore with three clinics located at Singapore's premier hospitals and medical centers. With specialists in coronary intervention, heart rhythm management, heart failure, cardiac imaging, and cardio thoracic surgery, NHC offers patients collaborative expertise within the same practice which ensures the best possible care and outcome for patients.
To learn more about NHC, please visit www.novenaheartcentre.com.sg
